NCT03068481View on ClinicalTrials.gov

Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 20, 2017

Primary Completion Date

August 13, 2018

Study Completion Date

August 13, 2018

Conditions
Parkinson Disease
Interventions
DRUG

KDT-3594

Oral administration

DRUG

Placebo

Oral administration

Trial Locations (1)

Unknown

Kyushu and Other Regions

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY